Skip to main content
logo
Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
3.590
-0.040 (-1.10%)
At close: Oct 30, 2026, 4:00 PM EDT
3.630
+0.040 (1.11%)
After-hours: Oct 30, 2026, 7:51 PM EDT

Wave Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-210.53-204.38-97.01-57.51-161.82-122.25
Depreciation & Amortization
9.238.858.669.2110.119.84
Loss (Gain) From Sale of Assets
----0.01-
Stock-Based Compensation
37.4424.9713.149.817.1916.41
Change in Accounts Receivable
-20.1519.66-21.09-30
Change in Accounts Payable
4.68-0.563.42-3.769.35-6.57
Change in Unearned Revenue
-36.76-19.83-93.5954.33-3.25-18.46
Change in Other Net Operating Assets
-8.513.31-5.32-10.40.622.04
Operating Cash Flow
-207.05-187.49-151.03-19.43-127.78-88.99
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.34-0.72-0.94-1.12-1.36-0.56
Sale of Property, Plant & Equipment
----0.11-
Investing Cash Flow
-234.75-0.72-0.94-1.12-1.26-0.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
396.05441.3239.81132.5352.9255.83
Other Financing Activities
46.9446.9414.08-14.27-
Financing Cash Flow
442.99488.24253.89132.5367.1955.83

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.070.01-0.14-0.1-0.21-0.21
Net Cash Flow
1.12300.04101.79111.89-62.06-33.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-208.39-188.21-151.96-20.55-129.14-89.55
Free Cash Flow Growth
------
Free Cash Flow Margin
-293.83%-440.50%-140.31%-18.13%-3539.11%-218.61%
Free Cash Flow Per Share
-1.06-1.12-1.10-0.19-1.64-1.73
Levered Free Cash Flow
-132.66-112.55-107.8464.11-67.01-78.24
Unlevered Free Cash Flow
-132.66-112.55-107.8464.11-67.01-78.24

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-42.59-16.94-75.8219.086.727.01
SEC Filings: 10-K · 10-Q